12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Quantitative Microsphere System regulatory update

Thermo Fisher said it received CE Mark approval for its Quantitative Microsphere System (QMS) Everolimus Immunoassay to monitor blood levels of everolimus in liver transplant patients. The assay...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >